Human umbilical cord blood, which in the past was discarded with the p
lacental tissue, provides a convenient source of fetal hemopoietic cel
ls for scientific analysis and clinical use. Cord blood cells are imma
ture compared to analogous populations in adult peripheral blood. Cord
blood B lymphocytes display unique phenotypic and functional characte
ristics. The antigens CD1C, CD38, CD5, and CD23, although normally exp
ressed on only a small percentage of circulating B cells in adults, ar
e highly expressed on cord blood B cells. Recent studies have demonstr
ated that whereas cord blood B cells are functionally naive, their pot
ential is similar to that of adult B cells if optimal T-cell help is a
vailable. Thus, the failure of B-cell responses in cord blood is due t
o the T cells. The functional abnormalities of T cells from newborns c
an be summarized as a dominance of the effects of THO cells. Thus, the
cytokines produced are immunosuppressive rather than mediating helper
activity for B cells. NK activity in cord blood is also depressed com
pared to that in adults. Cord blood is a very rich source of hemopoiet
ic progenitor eels. The spectrum of progenitors shows a predominance o
f early progenitor cells when compared with bone marrow. These cells p
rovide an alternative source to adult bone marrow for stem cells to us
e for hemopoietic reconstitution and as targets in the treatment of he
reditary deficiencies by gene therapy. These features make cord blood
a unique research tool to investigate hemopoietic ontogeny and a uniqu
e clinical tool for transplantation.